Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule
NCT ID: NCT05741554
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2021-09-01
2022-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Salpingectomy on Ovarian Reserve
NCT02284711
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
NCT01893086
Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy
NCT03921138
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
NCT03187327
Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.
NCT07120529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myometrial involvement
Myometrial involvement by cancer metastasis after pathology examination
Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
Presence of uterine myometrial metastasis at pathology examination after cytoreductive surgery
No myometrial involvement
Absence of myometrial involvement by cancer metastasis after pathology examination
Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
Presence of uterine myometrial metastasis at pathology examination after cytoreductive surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
Presence of uterine myometrial metastasis at pathology examination after cytoreductive surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* low grade serous ovarian cancer (MDACC classification)
* Grade 1 serous ovarian carcinoma (Silverberg classification)
Exclusion Criteria
* grade 2 and 3 serous ovarian carcinoma
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_0175
Identifier Type: OTHER
Identifier Source: secondary_id
22-5035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.